Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF

NCT02589977 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure, Diastolic
Diastolic Heart Failure
Hypertension

Interventions

DRUG: regadenoson

Sponsor

Marvin W. Kronenberg, M.D.

Collaborators

[object Object]